Reversing the Tide: New Medicine Targets Root Causes of Aging
Scientists are increasingly focused on inflammaging
– a state of chronic, low-grade inflammation that develops wiht age and substantially contributes to age-related diseases [[2]]. As the immune system weakens, immune cells release cytokines, which, while beneficial in small amounts for fighting infections, become detrimental in large quantities, triggering harmful inflammation.
This persistent inflammation accelerates aging processes, leading to DNA errors and altered gene activity. These changes weaken organs and their ability to maintain themselves, manifesting as common aging symptoms like wrinkles, gray hair, and muscle loss.
Moast older individuals develop inflammageing, a condition characterized by elevated levels of blood inflammatory markers that carries high susceptibility to chronic morbidity, disability, frailty, and premature death.
Inflammageing: chronic inflammation in ageing, cardiovascular disease
A Potential Breakthrough: Targeting CDC42 to Combat Aging
Researchers, led by Florian, are exploring innovative approaches to combat aging by targeting its root causes.Their focus is on the protein CDC42, suspected to play a crucial role in immune system deterioration and overall aging.
The team developed a medicine,Casin,designed to block CDC42’s activity. The hope is that Casin will prevent the protein from negatively impacting the immune system, effectively slowing down, or even reversing, the aging process.
The Senescence-Associated Secretory Phenotype (SASP) and Inflammaging
The link between DNA repair,inflammation,and aging is becoming increasingly clear. Senescent cells,often referred to as zombie cells
[[3]], secrete inflammatory molecules, a phenomenon known as the senescence-associated secretory phenotype (SASP) [[1]]. High levels of these secretions can lead to inflammaging, which is associated with numerous age-related diseases.
While research is ongoing, the progress of drugs like Casin offers a promising avenue for addressing inflammaging and perhaps extending healthy lifespans. The ability to target specific proteins like CDC42 could revolutionize how we approach age-related decline.
